Diabetes and egg donation eligibility depend heavily on which type you have and how well it is managed. The answer is not the same for Type 1 and Type 2, and it’s worth understanding why before you apply.
Type 1 diabetes is generally a disqualifying condition for egg donation. It is an autoimmune disease with a heritable component, and the insulin-dependent nature creates complications for ovarian stimulation. Type 2, which is metabolic in origin and often managed through lifestyle or oral medication, is evaluated case by case.
At Lucina Egg Bank, donors with complex health histories are reviewed individually. If you have diabetes and are considering donating, this article explains what the screening process looks at, what the distinctions between types mean in practice, and what factors might affect your eligibility.
Type 1 Diabetes and Egg Donation
Type 1 diabetes is an autoimmune condition in which the immune system destroys the insulin-producing beta cells in the pancreas. It requires lifelong insulin therapy and carries a heritable risk that is relevant to egg donation screening.
Type 1 diabetes is generally a disqualifying condition for egg donation. Type 2 diabetes is evaluated individually based on severity and management. Gestational diabetes that has resolved is not disqualifying. Prediabetes is assessed on current metabolic health. If you have any form of diabetes, disclose it fully during your application and let the clinical team make the determination.
There are two main reasons Type 1 diabetes typically disqualifies egg donors. First, it is heritable. NIDDK Type 1 data shows children of a parent with Type 1 have a 1–9% lifetime risk, compared to 0.4% in the general population.
That heritable risk is disclosed to intended parents and factors into their selection decisions. Second, the hormonal and metabolic disruption caused by Type 1 can interfere with ovarian stimulation, making protocols less predictable and potentially less safe.
The autoimmune dimension is also relevant. Donors with autoimmune conditions are evaluated carefully because autoimmune disease can affect ovarian reserve and response to stimulation medications.
Type 2 Diabetes: A Case-by-Case Evaluation
Type 2 diabetes is a metabolic condition, not an autoimmune one. It develops through a combination of insulin resistance and impaired insulin secretion, strongly associated with lifestyle factors. Its heritability profile and clinical implications for egg donation are meaningfully different from Type 1.
Programs that evaluate Type 2 donors individually typically look at these factors:
- Current management: Donors managing Type 2 through diet and exercise alone represent a very different clinical picture from those on oral medication or insulin. The closer to diet-only management, the more likely a program will consider the application.
- HbA1c level: This blood test reflects average blood glucose over the past two to three months. A well-controlled HbA1c close to the normal range is a positive indicator. Poorly controlled glucose complicates stimulation and increases procedural risk.
- Duration and progression: Newly diagnosed, well-controlled Type 2 is a different situation from long-standing Type 2 with secondary complications.
- Insulin dependence: Insulin-dependent Type 2 is generally treated similarly to Type 1 from a donor screening perspective, with the same concerns about stimulation complexity and heritability.
- BMI and metabolic markers: Type 2 is closely associated with BMI. If metabolic health markers are otherwise in range, this context matters to the overall assessment.
If you have Type 2 diabetes and want to understand your eligibility before applying, get your most recent HbA1c result. A result in or near the normal range (below 5.7% is normal; 5.7–6.4% is prediabetes; 6.5%+ is diabetic) gives the clinical team concrete data to work with alongside your application.
Gestational Diabetes and Prediabetes
These two situations are handled differently from diagnosed diabetes and are worth addressing directly.
Gestational diabetes develops during pregnancy due to hormonal changes that temporarily impair insulin sensitivity. It resolves in most cases after delivery.
If you had gestational diabetes that resolved postpartum and your current glucose levels are normal, it is treated as part of your obstetric history, not as an active medical condition. You will be asked about it during screening, but it does not disqualify you.
A history of gestational diabetes slightly increases the lifetime risk of developing Type 2, according to ACOG guidance on gestational diabetes. If screening bloodwork shows high fasting glucose, that will be reviewed in context. Normal results move you forward without issue.
Prediabetes means your blood glucose is above the normal range but not yet diabetic. It is not diabetes. Donors with prediabetes are assessed based on current metabolic health. Normal or near-normal HbA1c, regular cycles, and good ovarian reserve all count in your favour alongside the prediabetes notation.
Apply and let Lucina’s clinical team review your specific situation. Disclosure is always the right move, and the team will give you an honest answer. Standard donors earn $8,000–$15,000+ per cycle. Iconic donors at top-ranked universities earn up to $50,000 per cycle.
Start Your ApplicationThe 6-Step Screening Process for Donors with Diabetes History
Here is how the process unfolds for a donor disclosing diabetes or a related health history.
Disclose your diabetes type, how long you’ve had it, your current management method, and any medications. Include your most recent HbA1c if you have it. Honest disclosure here sets the right foundation.
Lucina’s team reviews your application. Type 1 diabetes disclosed here will typically result in a non-approval at this stage. Type 2 or gestational history is flagged for physician review at screening.
Standard bloodwork includes hormone markers and metabolic screening. HbA1c and fasting glucose are reviewed alongside AMH, FSH, and estradiol. These results give the physician a complete metabolic picture.
A transvaginal ultrasound assesses ovarian reserve through antral follicle count. Diabetes, particularly Type 2 with PCOS overlap, can affect ovarian morphology. The scan gives direct visual data beyond what bloodwork shows.
All findings are reviewed together. For Type 2 donors, this is where management level, HbA1c, and ovarian reserve results are weighed against each other. The physician determines if the clinical picture supports proceeding.
You receive a clear decision: approved to proceed, deferred pending additional information, or not approved. The reasoning is communicated to you. Non-approval due to diabetes type is a medical decision, not a reflection of your character or commitment.
How Diabetes Affects Ovarian Function
Heritability is one reason Type 1 typically disqualifies donors. The ovaries are a separate concern. Diabetes affects follicular development through mechanisms distinct from genetic inheritance.
Research published in Fertility and Sterility found that women with Type 1 diabetes may have lower AMH levels and reduced antral follicle counts compared to non-diabetic peers of the same age. Chronic hyperglycemia and the autoimmune environment associated with Type 1 can affect follicular development over time.
Type 2 diabetes with insulin resistance can also affect ovarian function, particularly when it overlaps with PCOS. Insulin resistance is a shared feature of both conditions and can lead to higher androgen levels, anovulatory cycles, and an abnormal ovarian response to stimulation.
Egg donor screening follows FDA donor screening requirements and ASRM guidelines for third-party reproduction. Neither framework lists specific HbA1c cutoffs for donor eligibility, but both require thorough evaluation of donor health. Individual programs set their own thresholds based on safety and outcome data.
What to Do Next
If you have Type 1 diabetes, the likelihood of qualifying is low, for clear medical and ethical reasons. That said, applying and disclosing is still the right move if you’re uncertain, because the clinical team’s assessment is more definitive than any general guidance.
If you have Type 2 diabetes, prediabetes, or a history of gestational diabetes, there is a real path forward depending on your current health status. The more controlled your glucose and the lighter your medication load, the stronger your case.
Lucina is the Largest Egg Bank in the USA with 3,500+ screened profiles. Disqualifying conditions span genetic, reproductive, and lifestyle factors beyond diabetes. Donor screening involves bloodwork, ultrasound, genetic testing, and physician review. Our clinical partner network shows coordinating clinics across the U.S., and why donors choose Lucina covers what the full experience looks like.
Apply to Donate Eggs With Lucina
Lucina reviews donors individually. Our clinical team looks at your full picture, not just a diagnosis label. Apply and get a clear answer about where you stand.
$8,000–$15,000+ per cycle (Standard) · Up to $50,000 per cycle (Iconic) · 3,500+ screened donors
All medical and travel costs covered. Compensation paid after retrieval. Up to 6 donation cycles allowed per ASRM lifetime guidelines.
Frequently Asked Questions
Julianna Nikolic
Chief Strategy Officer Julianna Nikolic leads strategic initiatives, focusing on growth, innovation, and patient-centered solutions in the reproductive sciences sector. With 26+ years of management experience and a strong entrepreneurial background, she brings deep expertise to advancing reproductive healthcare.
